2 news items
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
ADTN
AMBC
AORT
7 May 24
Yigal Nochomovitz initiated coverage on Summit Therapeutics with a Buy rating and announced a price target of $7.
Hims & Hers
Jumia Reports First Quarter 2024 Results
JMIA
7 May 24
, growth does not require heavy spending. Rather, a deep understanding and appreciation of the African ecommerce market, along with a targeted growth
- Prev
- 1
- Next